Steven Flamm, MD
Enriched profileProfessor of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush Medical College; Director of Research, Section of Hepatology; Clinical Director of Network Development and Outreach, Transplant Service Line, Rush University Medical Center · Rush University Medical Center
Steven Flamm is Professor of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush Medical College; Director of Research, Section of Hepatology; Clinical Director of Network Development and Outreach, Transplant Service Line, Rush University Medical Center at Rush University Medical Center. ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Steven L. Flamm, MD, is Professor of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush Medical College at Rush University Medical Center / Rush Medical College. The public record shows 259 publications with 14,060 citations (h-index 46), centered on Gastroenterology. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 26 companies, 1 NIH-funded awards (1998–2004).
- Top research focus: Gastroenterology
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 26 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Sponsor: Veloxis Pharmaceuticals
Industry payments
Updated 27 Aug 2026
26 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year202550 payments$105,497openpaymentsdata.cms.gov ↗
- Madrigal PharmaceuticalsProgram year202559 payments$89,304openpaymentsdata.cms.gov ↗
- Ipsen Biopharmaceuticals, IncProgram year202524 payments$69,926openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
44.7%Rifamycin Antibacterial31%Xifaxan100%Part D≥20 patientsBile Acid10.6%Ursodiol100%Part D<11 patientsCardiovascular
23.5%Loop diuretic12.2%Furosemide100%Part D≥23 patientsAldosterone antagonist (MRA)11.4%Spironolactone100%Part D≥15 patientsAnti-infectives
17.5%Nucleoside and nucleotide reverse transcriptase inhibitors13.2%Tenofovir Disoproxil Fumarate74%Vemlidy26%Part D<11 patientsHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor4.2%Epclusa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 1998–2004 per NIH RePORTER. The latest:
- Dose Comparison Study of PEG-Interferon Alfa-2b + Ribavirin
Northwestern University
FY2004$5,856M01RR000048 - Comparison Study of PEG Interferon alfa-2b+Ribavirin in Prev. Untreated Adults
Northwestern University
FY2004$3,904M01RR000048 - INTRON A VS INTRON A PLUS RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS C
Northwestern University
FY2001M01RR000048
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review
Clinical Gastroenterology and Hepatology
2022 - Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis
CardioVascular and Interventional Radiology
2021
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/steven-flamm-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/steven-flamm-128147163
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
rushu.rush.edu/faculty/steven-flamm-md-faasld-facg
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗
Mentions by others
where others cite or feature them- Other
mdnewsline.com/a-conversation-with-transplant-hepatologist-gastroenterologist-dr-steven-flamm
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdnewsline.com ↗ - Other
aasld.org/membership/member-resources/member-committees/industry-advancement-committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Other
rushliverconference.org/faculty-2024
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushliverconference.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗
- Internal Medicine internship and residency
Beth Israel Hospital, Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗ - Fellowship
Gastroenterology, Beth Israel Hospital, Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗ - Fellowship
Hepatology and Liver Transplantation, Deaconess Hospital, Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗ - Board certified
Gastroenterology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.rush.edu ↗ - Board certified
Transplant Hepatology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.rush.edu ↗
Editorial & leadership roles
journal and society appointments- Fellow
American Association for the Study of Liver Diseases (FAASLD)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗ - Fellow
American College of Gastroenterology (FACG)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rushu.rush.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.rush-health.com ↗
- Formerly Chief of Hepatology Program and Medical Director of Liver Transplantation
Northwestern Memorial Hospital / Feinberg School of Medicine, Northwestern University (prior role …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nm.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗
- Podcast on alcohol-associated liver disease (ALD/MetALD) with Dr. Mack Mitchell
Chronic Liver Disease Foundation / Liver Connect podcast series
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chronicliverdisease.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mdnewsline.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Christopher Goetz, MD
Rush University Medical Center
Theodore Pincus, MD
Rush University Medical Center
Christopher Seder, MD
Rush University Medical Center
Melody Cobleigh, MD
Rush University Medical Center